Asthma, Bronchial Clinical Trial
Official title:
A Double Blind, Double Dummy, Randomised, Multicentre, Four Arm Parallel Group Study to Assess the Efficacy and Safety of FlutiForm® pMDI 250/10µg (2 Puffs Bid) vs Fluticasone pMDI 250µg (2 Puffs Bid) Plus Formoterol pMDI 12µg (2 Puffs Bid) Administered Concurrently in Adult Subjects With Severe Persistent, Reversible Asthma.
The study compares the efficacy and safety of FlutiForm® vs Flixotide® plus Foradil® in the treatment of severe persisent asthma in adult subjects.
This is a study involving a 2 week run-in phase followed by an 8 week double blind treatment phase. During the run-in phase, subjects receive Flixotide®. In the treatment phase subjects will be randomised to one of the four treatment groups and will receive either high dose FlutiForm® and Foradil® plus Flixotide® placebo or low dose FlutiForm® plus Foradil® and Flixotide® placebo or Foradil® plus Flixotide® and FlutiForm® placebo or Flixotide® and FlutiForm® plus Foradil® placebo. Efficacy will be assessed by lung function tests, asthma symptoms, sleep disturbance due to asthma and rescue medication use. Safety will be assessed by adverse events, lab tests, ECGs and vital signs. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT00825903 -
The Effects of Exercise on Physiological and Psychological Parameters in an Asthmatic Population
|
N/A | |
| Terminated |
NCT00385593 -
Symbicort Single Inhaler Therapy vs Conventional Best Practice for the Treatment of Persistent Asthma in Adults
|
Phase 3 | |
| Completed |
NCT00213252 -
Use of Montelukast to Treat Children With Mild to Moderate Acute Asthma
|
Phase 2 | |
| Completed |
NCT00092092 -
Study of Montelukast and Its Effect on Lower Leg Growth in Children With Asthma (MK-0476-254)
|
Phase 4 | |
| Completed |
NCT00489346 -
A Study to Evaluate MK0476 and Fluticasone to Control Asthma in Patients With Mild Persistent Asthma (0476-910)
|
Phase 3 | |
| Withdrawn |
NCT03989635 -
Mechanistic Study of Anti-inflammatory Effects of Fevipiprant in Patients With Eosinophilic Asthma.
|
Phase 2 | |
| Withdrawn |
NCT00540839 -
A Study of Montelukast (MK-0476) Compared With Fluticasone in Pediatric Participants With Chronic Asthma (MK-0476-303)
|
Phase 3 | |
| Recruiting |
NCT06299306 -
REACT - REAl Care for AsThma - A Disease Study to Identify Patients With Severe Uncontrolled Asthma
|
||
| Recruiting |
NCT00312312 -
Allergy Towards Grass and Bronchial Inflammation - Related to Immunotherapy and Exhaled Nitrogen Oxide
|
N/A | |
| Completed |
NCT00092885 -
An Approved Drug to Study a New Indication for Seasonal Allergic Rhinitis in Patients With Asthma (0476-269)
|
Phase 3 | |
| Not yet recruiting |
NCT06422078 -
A Non-interventional, Prospective Study With Benralizumab
|
||
| Completed |
NCT02805907 -
Efficacy of Calcifediol Supplementation in Asthma Control in Asthmatic Patients With Vitamin D Deficiency (ACViD)
|
Phase 4 | |
| Not yet recruiting |
NCT00644462 -
Wheeze Detection in Adults During Dynamic Bronchial Situations Measured by PulmoTrack® 2010 With WIM-PC™ Technologies Recording
|
N/A | |
| Completed |
NCT03839433 -
The Mannitol-Asthma-Ciclesonide-Study
|
Phase 4 | |
| Completed |
NCT00640120 -
Wheeze Detection in Children During Dynamic Bronchial Situations Measured by WIM-PC™ Recording
|
N/A | |
| Recruiting |
NCT05937334 -
The Cohort Study for Asthma in China
|
||
| Completed |
NCT03034447 -
Sleep Apnea in Asthmatic Children and Teenagers
|
N/A | |
| Completed |
NCT05270278 -
Characteristics of Type 2- High Inflammatory Endotype of Asthma Using New Biomarkers From Peripheral Blood and Exhaled Air and Its Effect on the Outcome of Therapy
|
||
| Withdrawn |
NCT00830427 -
A Study To Examine The Safety And Efficacy Of PF-00610355 In Moderately Asthmatic Subjects
|
Phase 2 | |
| Completed |
NCT00092105 -
Study of MK0476 (Montelukast Sodium) and Effects on Asthma and Nasal Symptoms Upon Exposure to Cats (0476-256)
|
Phase 3 |